Skip NavigationSkip to Content

Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells

  1. Author:
    Inadera, H.
    Sekiya, T.
    Yoshimura, T.
    Matsushima, K.
  2. Author Address

    Matsushima K Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku 7-3-1 Hongo Tokyo 1130033 Japan Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku Tokyo 1130033 Japan NCI, Immunopathol Sect, Mol Immunoregulat Lab, Frederick Canc Res & Dev Ctr Frederick, MD 21702 USA
    1. Year: 2000
  1. Journal: Endocrinology
    1. 141
    2. 1
    3. Pages: 50-59
  2. Type of Article: Article
  1. Abstract:

    Xenoestrogens (XEs) are a diverse group of chemicals that mimic estrogenic actions and may have adverse effects on human health. The influence of these compounds on cytokine production or immune system function remains unclear. In this study we have examined the effects of 17 beta-estradiol (E-2) and XEs on chemoattractant cytokine (chemokine) production and analyzed the molecular mechanism. Monocyte chemoattractant protein-1 (MCP-1), also termed monocyte chemotactic and activating factor, is a member of the chemokine family and attracts mainly blood monocytes. Human mammary tumor cell Line MCF-7 cells produce a large quantity of MCP-1 in response to interleukin-1 alpha (IL-1 alpha). Addition of E-2 to MCF-7 cells inhibited MCP-1 production in a dose-dependent manner. XEs, bisphenol A, and NP also inhibited MCP-1 production, although the potency was 3-4 orders of magnitude lower than that of E-2. E-2, bisphenol A, and NP inhibited MCP-1 messenger RNA expression in MCF-7 cells. Two closely located nuclear factor-kappa B sites, Al and A2, have been identified in the promoter of the human MCP-1 gene. A luciferase construct containing this enhancer region (pGLM-ENH) was activated by IL-la, and a mutation at either the Al or A2 site resulted in a loss of IL-la responsiveness. Treatment with E-2 or XEs decreased the IL-la-inducible pGLM-ENH luciferase activity significantly. In an electrophoretic mobility shift assay and supershift analysis, we found that treatment with E-2 or XEs diminished the IL-1 alpha-induced complex formation with both Al and A2 probes, which was identified immunochemically to consist of nuclear factor-kappa B, p50, and p65. The IL-1 alpha-induced p50/c-Rel complex to the A2 probe was also, to a lesser extent, decreased by E-2 or XE treatment. The effects of E-2 and XEs on the expression of MCP-1 seem to be much more dramatic than the effects of these agents on the promoters used in the luciferase assay, suggesting the involvement of an additional site(s) of the promoter region of the MCP-1 gene or posttranscriptional regulation of MCP-1 gene expression by E-2 and XEs. This work represents the first report describing possible regulation of immune system function by XEs through inhibiting chemokine production. [References: 45]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel